Literature DB >> 12698070

Factors that influence the risk of hypertension in obese individuals.

Gwenn Coatmellec-Taglioni1, Catherine Ribière.   

Abstract

PURPOSE OF REVIEW: Obesity, which has reached epidemic prevalence, is now recognized as an independent risk factor for increasing blood pressure. The complex mechanisms of obesity-related hypertension are unclear, but several studies have provided evidence of a hypertensive shift in pressure natriuresis. Excess sympathetic outflow to the kidneys and changes in renal structure and function may both affect the renal pressure relationship. Other factors that may contribute to altered natriuresis include hyperinsulinemia, hyperleptinemia and activation of the renin-angiotensin system. Disruption of the renal alpha2 adrenoceptors or leptin receptor implicated in natriuresis control may also be an additive risk for the increase in tubular reabsorption in obesity hypertension. RECENT
FINDINGS: Recent advances have highlighted the importance of two adipocyte-derived hormones - leptin and angiotensinogen - in obesity hypertension. Leptin has direct central effects that increase sympathetic outflow to the kidney and the new concept of selective leptin resistance, suggests the maintenance of leptin-induced sympathetic activation in obesity, despite resistance to leptin metabolic effects. On the other hand, a recent study showed that angiotensinogen produced in the adipocyte is also relevant to blood pressure control.
SUMMARY: The article reviews the factors implicated in the disruption of blood pressure control in obesity. Further investigation on the time course of the disease would reveal the relative importance of each of the factors that influence the risk of hypertension in obese individuals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12698070     DOI: 10.1097/00041552-200305000-00013

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  10 in total

1.  Down-regulation of the epithelial Na⁺ channel ENaC by Janus kinase 2.

Authors:  Zohreh Hosseinzadeh; Dong Luo; Mentor Sopjani; Shefalee K Bhavsar; Florian Lang
Journal:  J Membr Biol       Date:  2014-02-23       Impact factor: 1.843

Review 2.  Cardiac NO signalling in the metabolic syndrome.

Authors:  O Pechánová; Z V Varga; M Cebová; Z Giricz; P Pacher; P Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

Review 3.  Cardiovascular complications of obesity in adolescents.

Authors:  F Orio; S Palomba; T Cascella; S Savastano; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  2007-01       Impact factor: 4.256

4.  Medical complications of obesity and optimization of the obese patient for colorectal surgery.

Authors:  Nell Maloney Patel; Manish S Patel
Journal:  Clin Colon Rectal Surg       Date:  2011-12

Review 5.  Adiposopathy is a more rational treatment target for metabolic disease than obesity alone.

Authors:  Harold Bays; Carlos A Dujovne
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

6.  Intravenous intralipid-induced blood pressure elevation and endothelial dysfunction in obese African-Americans with type 2 diabetes.

Authors:  Guillermo E Umpierrez; Dawn Smiley; Gonzalo Robalino; Limin Peng; Abbas E Kitabchi; Bobby Khan; Ahn Le; Arshed Quyyumi; Virgil Brown; Lawrence S Phillips
Journal:  J Clin Endocrinol Metab       Date:  2008-11-11       Impact factor: 5.958

7.  Association of aldosterone and cortisol with cardiovascular risk factors in prehypertension stage.

Authors:  Sadiqa Badar Syed; Masood Anwar Qureshi
Journal:  Int J Hypertens       Date:  2012-08-16       Impact factor: 2.420

8.  Blood pressure relation to body composition and age: analysis of a nurse-led investigation and consultation program.

Authors:  Mária Boledovičová; Jan Hendl; Lubica Lišková; Alica Slamková; Martin Matoulek; Zuzana Stránská; Štěpán Svačina; Miloš Velemínský
Journal:  Med Sci Monit       Date:  2013-07-26

9.  Obesity and hypertension.

Authors:  Shu-Zhong Jiang; Wen Lu; Xue-Feng Zong; Hong-Yun Ruan; Yi Liu
Journal:  Exp Ther Med       Date:  2016-09-06       Impact factor: 2.447

10.  Effects of Virgin Olive Oil on Blood Pressure and Renal Aminopeptidase Activities in Male Wistar Rats.

Authors:  Germán Domínguez-Vías; Ana Belén Segarra; Manuel Ramírez-Sánchez; Isabel Prieto
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.